The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Clinical trial NCT01249365 · COMPLETED
Trial details
- NCT number
- NCT01249365
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-24
- Primary completion
- 2017-01-10
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.